Advanced search
Publication Cover
Journal of Chemotherapy Volume 30, 2018 - Issue 1
Submit an article Journal homepage
199
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Hepatic veno-occlusive disease during isavuconazole administration

Alessio MesiniInfectious Diseases Division, University of Genoa (DISSAL), Genoa, ItalyORCID Iconhttp://orcid.org/0000-0003-0593-4112
ORCID Icon,
Giuliana CangemiClinical Pahology Laboratory Unit, Istituto Giannina Gaslini, Genoa, ItalyORCID Iconhttp://orcid.org/0000-0001-6847-5983
ORCID Icon,
Elena PalmisaniHematology Unit, Istituto Giannina Gaslini, Genoa, Italy
,
Carlo DufourHematology Unit, Istituto Giannina Gaslini, Genoa, Italy
&
Elio CastagnolaInfectious Diseases Unit, Istituto Giannina Gaslini, Genoa, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5336-8429
ORCID Icon
Pages 63-64 | Published online: 26 Dec 2017

References

  • Miceli MH, Kauffman CA. Isavuconazole: A new broad-spectrum triazole antifungal agent. Clin Infect Dis. 2015;61(10):1558–65. Epub 2015/07/17. doi:10.1093/cid/civ571. PubMed PMID: 26179012.
  • Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163(4):444–57. Epub 2013/10/10. doi:10.1111/bjh.12558. PubMed PMID: 24102514.
  • Pana ZD, Kourti M, Vikelouda K, Vlahou A, Katzilakis N, Papageorgiou M, et al. Voriconazole antifungal prophylaxis in children with malignancies: A nationwide study. J Pediatr Hematol/Oncol. 2017. Epub 2017/08/18. doi:10.1097/mph.0000000000000926. PubMed PMID: 28816795.
  • Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16(2):157–68. Epub 2009/09/22. doi:10.1016/j.bbmt.2009.08.024. PubMed PMID: 19766729; PubMed Central PMCID: PMCPMC3018714.
  • Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22(3):400–9. Epub 2015/10/04. doi:10.1016/j.bbmt.2015.09.024. PubMed PMID: 26431626.
  • Rybak JM, Marx KR, Nishimoto AT, Rogers PD. Isavuconazole: Pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent. Pharmacotherapy 2015;35(11):1037–51. Epub 2015/11/26. doi:10.1002/phar.1652. PubMed PMID: 26598096.
  • Kyriakidis I, Tragiannidis A, Munchen S, Groll AH. Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf. 2017;16(2):149–65. Epub 2016/12/09. doi:10.1080/14740338.2017.1270264. PubMed PMID: 27927037.
  • Groll AH, Desai A, Han D, Howieson C, Kato K, Akhtar S, et al. Pharmacokinetic assessment of drug–drug interactions of isavuconazole with the immunosuppressants cyclosporine, mycophenolic acid, prednisolone, sirolimus, and tacrolimus in healthy adults. Clin Pharmacol Drug Dev. 2017;6(1):76–85. Epub 2016/06/09. doi:10.1002/cpdd.284. PubMed PMID: 27273343; PubMed Central PMCID: PMCPMC5298005.
  • Girmenia C, Iori AP. An update on the safety and interactions of antifungal drugs in stem cell transplant recipients. Expert Opin Drug Saf. 2017;16(3):329–39. Epub 2016/12/23. doi:10.1080/14740338.2017.1273900. PubMed PMID: 28004589.
  • Natesan SK, Chandrasekar PH. Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations. Infect Drug Resist. 2016;9:291–300. Epub 2016/12/21. doi:10.2147/idr.s102207. PubMed PMID: 27994475; PubMed Central PMCID: PMCPMC5153275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.